Curcumin was reported to synergize with FOLFOX to induce growth inhibition on chemo-resistant CRC cells, which were associated with the reduced activation of EGFR, HER-2, IGF-1R, and AKT, as well as the downregulation of COX-2 and cyclin-D [95]. Here, IGF1R is linked to colorectal carcinoma.